VECTICANN
Live / Registered — Registered (as of 21 Apr 2026)
What this means for you
Registered since 21 Apr 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 21 Apr 2032: the §71 affidavit of use).
Record
- Serial number
- 79418894
- Registration number
- 8217386
- Mark type
- Word mark
- Filed
- 06 Jan 2025
- Published for opposition
- 03 Mar 2026
- Registered
- 21 Apr 2026
- Next maintenance filing
- §71 affidavit of use, due by 21 Apr 2032 (grace period to 21 Oct 2032)
- Attorney of record
- Scott McCollister
Goods and services
- Class 005 — Pharmaceuticals: Medicinal preparations for treatment of intractable nausea and vomiting associated with chemotherapy, fibromyalgia, chronic pain disorders, spasticity, Parkinson's disease, multiple sclerosis, insomnia, anxiety, PTSD, severe treatment-resistant epilepsy, Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, Crohn's disease and ulcerative colitis; transdermal patches for use in the treatment of intractable nausea and vomiting associated with chemotherapy, fibromyalgia, chronic pain disorders, spasticity, Parkinson's disease, multiple sclerosis, insomnia, anxiety, PTSD, severe treatment-resistant epilepsy, Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, Crohn's disease and ulcerative colitis; adhesive skin patches for medical purposes, namely, treatment of intractable nausea and vomiting associated with chemotherapy, fibromyalgia, chronic pain disorders, spasticity, Parkinson's disease, multiple sclerosis, insomnia, anxiety, PTSD, severe treatment-resistant epilepsy, Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, Crohn's disease and ulcerative colitis; medicated skin preparations, namely skin patches, for treatment of intractable nausea and vomiting associated with chemotherapy, fibromyalgia, chronic pain disorders, spasticity, Parkinson's disease, multiple sclerosis, insomnia, anxiety, PTSD, severe treatment-resistant epilepsy, Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, Crohn's disease and ulcerative colitis
Owner
Prosecution history
- 15 Oct 2026 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 28 Sept 2026 — FINAL DISPOSITION NOTICE SENT TO IB
- 28 Sept 2026 — FINAL DISPOSITION PROCESSED
- 27 Aug 2026 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 12 Aug 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 12 Aug 2026 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 21 Jul 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 21 Apr 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Apr 2026 — REGISTERED-PRINCIPAL REGISTER
- 03 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Mar 2026 — PUBLISHED FOR OPPOSITION
- 26 Feb 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 25 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED